Vincent John Corvari

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 73(Granted Patents)

Location History:

Hockessin, DE (US) (1997)
Nashua, NH (US) (2001 - 2003)
Carmel, IN (US) (2007 - 2024)

Company Filing History:

8 out of 4,442

Eli Lilly and Company

Years Active: 1997-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12453756 - GIP/GLP1 agonist compositions (2025-10-28),

2. 12453755 - GIP/GLP1 agonist compositions (2025-10-28),

3. 11918623 - GIP/GLP1 agonist compositions (2024-03-05),

4. 11634485 - Therapeutic antibody formulation (2023-04-25),

5. 11357820 - GIP/GLP1 agonist compositions (2022-06-14),

6. 10472416 - IL-17 antibody formulations and methods of treatment using same (2019-11-12),

7. 9845353 - IL-17 antibody formulations and methods of treatment using same (2017-12-19),

8. 9376491 - IL-17 antibody formulation and method of treatment using same (2016-06-28),

9. 7297346 - Pharmaceutical formulations of modafinil (2007-11-20),

10. 7229644 - Pharmaceutical formulations of modafinil (2007-06-12),

11. 6660729 - Particle-forming compositions containing fused pyrrolocarbazoles (2003-12-09),

12. 6200968 - Particle-forming compositions containing fused pyrrolocarbazoles (2001-03-13),

13. 5618845 - Acetamide derivative having defined particle size (1997-04-08),

Title: Unveiling the Inventive Mind of Vincent John Corvari

Introduction:

Vincent John Corvari, a prolific inventor hailing from Carmel, IN, has left a significant mark in the world of patents with a total of 11 inventions to his name. His innovative spirit and dedication to scientific advancements have led to groundbreaking discoveries in the healthcare and pharmaceutical industries.

Latest Patents:

1. GIP/GLP1 agonist compositions - A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol, and dibasic sodium phosphate, revolutionizing therapeutic approaches.

2. Therapeutic antibody formulation - Stabilization of aqueous pharmaceutical formulations for therapeutic antibodies, enhancing the efficacy and shelf life of vital treatments.

Career Highlights:

Vincent Corvari has shared his expertise with esteemed companies such as Eli Lilly and Company, a renowned pharmaceutical giant, and Cephalon, Inc., a leader in biopharmaceutical innovation. Through his contributions, he has propelled these organizations towards pioneering advancements in healthcare.

Collaborations:

Throughout his career, Vincent has collaborated with industry experts such as Barbara Ann Williams and Patrick Daniel Donovan. Together, they have worked tirelessly to push the boundaries of scientific research and development, aiming to improve the quality of life for individuals worldwide.

Conclusion:

Inventor Vincent John Corvari's dedication, ingenuity, and collaborative spirit have cemented his legacy in the realm of innovations. His remarkable patents stand as a testament to his relentless pursuit of excellence in enhancing healthcare solutions and shaping a better future for generations to come.

This text is generated by artificial intelligence and may not be accurate.